Large companies report poor sales in Q2

The big boys of India Inc have put up a relatively poor show in Q2FY25 so far compared with smaller companies, with their net sales for the September quarter rising just 3% year-on-year.

This has dragged down the aggregate sales growth for a sample of 1,237 companies (excluding banks and financials and oil marketing companies) to just 5% y-o-y — the slowest in at least four quarters.

Thanks to their anaemic topline growth, the operating profit for the bigger companies grew by just 6% y-o-y. If they have managed to show some improvement in their bottomlines, it is thanks to a smaller increase in costs and also a big boost from other income. Moreover, some businesses have swung to a profit from a loss in the corresponding quarter –– Q2FY24.

On the other hand, businesses with a turnover of less than Rs 10,000 crore have posted a very decent 10% y-o-y growth in net sales, the highest in at least four quarters.

Some companies, however, have done well. At Dr Reddy’s Laboratories, sales were up 16.5% y-o-y, while engineering giant Larsen & Toubro put up a strong show posting a revenue growth of 21% y-o-y. Others like Mahindra & Mahindra, too, did well to post a standalone net revenue growth of 13% y-o-y, albeit driven mainly by price increases rather than volumes.

On the other hand, consolidated sales at Tata Steel have fallen by 3.2% y-o-y, while at Dalmia Bharat, they fell 2.1% y-o-y and at Tata Chemicals by 0.8% y-o-y. Revenues at Ashok Leyland were down 9% y-o-y, thanks to a big dip in volumes. Again, Hindustan Unilever revenues grew by just 3% y-o-y, while Dabur India’s revenues were down 5% y-o-y. At Tata Power, they were down 1% y-o-y.

Consumer companies have found it hard to grow their toplines at a time when urban demand has been slowing and rural demand is yet to fully recover.

The operating profit growth for the sample of 1,237 companies, of 6% y-o-y is the slowest in at least four quarters. They had expanded by 14%, 11% and 22% in the June, March and December quarters, respectively.

An analysis by Kotak Institutional Equities (KIE) identified more than 50 top-rung companies whose earnings before interest, tax, depreciation and amortisation (ebitda) in Q2FY25 grew by less than the “modest expectations”.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations